NEO1 and NEO-EXT studies: pharmacodynamic and exploratory biomarker assessments following repeat avalglucosidase alfa dosing for up to 4.5 years in patients with late-onset Pompe disease
MUSCLE & NERVE（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要